Harbin Pharmaceutical Group
Harbin Pharmaceutical Group Co., Ltd. is China's second-biggest drug maker by market value. The major shareholder of the company was for 47.06% stake, literally have the same English name with the listed subsidiary, as the listed subsidiary missed the word "Joint-Stock / Shares" in its English official name.Business
Harbin Pharmaceutical is engaged in the research, development, manufacture and sale of pharmaceutical products. The Company primarily offers antibiotics, Chinese patent medicines, over-the-counter medicines, healthcare products and synthesized preparations, among others.
During the year ended December 31, 2007, the Company obtained approximately 73% and 14% of its total revenue from the sale of western medicines and traditional Chinese medicines, respectively. As of December 31, 2007, the Company had two subsidiaries/associates: one specializes in manufacturing oral solutions, while the other is engaged in the retail and wholesale of pharmaceuticals.
